Diagnostic Validity of the Dementia Questionnaire for Alzheimer Disease | Dementia and Cognitive Impairment | JAMA Neurology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Original Contribution
March 1998

Diagnostic Validity of the Dementia Questionnaire for Alzheimer Disease

Author Affiliations

From the Departments of Neurosciences (Drs Ellis, Hansen, and Thal) and Psychiatry (Dr Jeste), University of California, San Diego; the San Diego Veterans Affairs Medical Center (Drs Ellis, Jeste, and Thal); Department of Medicine, the Cedars-Sinai Medical Center, Los Angeles, Calif (Dr Jan); Department of Neurology, The Johns Hopkins University, Baltimore, Md (Dr Kawas); and the Department of Neurology, University of Kansas, Kansas City (Drs Koller and Lyons).

Arch Neurol. 1998;55(3):360-365. doi:10.1001/archneur.55.3.360

Objective  To determine the sensitivity and specificity of postmortem dementia diagnoses based on a retrospective informant interview by comparison with criterion standard neuropathological diagnoses and the results of previous clinical examinations.

Setting  Three university-based academic research centers.

Subjects  Fifty-four deceased elderly persons with Alzheimer disease, another dementing disorder, a neurologic disease resulting in functional impairment but no dementia, or no neurologic disorder.

Methods  Blinded nonclinician interviewers administered the Dementia Questionnaire (DQ) by telephone to informants, typically close relatives, who were familiar with the intellectual and functional status of the subjects before death. Two senior clinicians (L.J.T. and C.K.) rated each DQ for the presence or absence of a dementia syndrome during life and for the specific disorders causing the dementia, if present. Raters were blinded to the neuropathological findings and based their assessments only on data provided by responses to the DQ. Comparison was made with diagnoses based on neuropathological assessment. In most cases, the results of antemortem clinical examinations were also available as a check on the clinical diagnosis of the dementia syndrome. Sensitivity and specificity of the DQ diagnoses were computed, and chance-corrected agreement measures were calculated for the 2 independent DQ raters (L.J.T. and C.K.).

Results  Compared with antemortem clinical diagnosis, the average sensitivity of the DQ for the clinical syndrome of dementia was 92.8%, the specificity was 89.5%, and the interrater agreement was 98% (κ=0.96). Among 7 subjects with mild dementia (Mini-Mental State Examination score ≥24 at the last clinical examination), 5 (71%) were correctly identified using the DQ. The DQ correctly indicated the absence of dementia in 8 (80%) of 10 subjects with other neurologic disorders causing functional impairment. Compared with the neuropathological diagnoses, the DQ differentiated Alzheimer disease from other primary causes of dementia with a sensitivity of 89% and a specificity of 72%. The interrater agreement was 93.8% (κ=0.85).

Conclusions  Compared with the results of the antemortem clinical examinations, the DQ was sensitive to the presence of dementia, detected most cases of mild dementia, and discriminated dementia from other neurologic disorders causing functional impairment. Compared with the neuropathological diagnoses, the ability of the DQ to differentiate Alzheimer disease from other dementing disorders indicates that it may be useful as a research tool.